See also
ˇ Show More
The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Pfizer Inc., Consolidated Income Statement
USD $ in millions
| 12 months ended | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | |
|---|---|---|---|---|---|---|
 |
Revenues | |
|
|
|
|
|
Cost of sales | |
|
|
|
|
|
Gross profit | |
|
|
|
|
|
Selling, informational and administrative expenses | |
|
|
|
|
|
Research and development expenses | |
|
|
|
|
|
Amortization of intangible assets | |
|
|
|
|
|
Acquisition-related in-process research and development charges | |
|
|
|
|
|
Restructuring charges and certain acquisition-related costs | |
|
|
|
|
|
Royalty-related income | |
|
|
|
|
|
Net gain (loss) on asset disposals | |
|
|
|
|
|
Legal matters, net | |
|
|
|
|
|
Gain related to ViiV | |
|
|
|
|
|
Certain asset impairment charges | |
|
|
|
|
|
Other, net | |
|
|
|
|
|
Other income (expense), net | |
|
|
|
|
|
Operating income | |
|
|
|
|
|
Interest income | |
|
|
|
|
|
Interest expense | |
|
|
|
|
|
Net interest income (expense) | |
|
|
|
|
|
Income from continuing operations before provision for taxes on income | |
|
|
|
|
|
Provision for taxes on income | |
|
|
|
|
|
Income from continuing operations | |
|
|
|
|
|
Discontinued operations, net of tax | |
|
|
|
|
|
Net income before allocation to noncontrolling interests | |
|
|
|
|
|
Net income attributable to noncontrolling interests | |
|
|
|
|
|
Net income attributable to Pfizer Inc. | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Revenues | Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. | Pfizer Inc.'s revenues increased from 2008 to 2009 and from 2009 to 2010. |
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Pfizer Inc.'s operating income increased from 2008 to 2009 but then slightly declined from 2009 to 2010. |
| Income from continuing operations before provision for taxes on income | Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. | Pfizer Inc.'s income from continuing operations before provision for taxes on income increased from 2008 to 2009 but then declined significantly from 2009 to 2010. |
| Income from continuing operations | This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. | Pfizer Inc.'s income from continuing operations increased from 2008 to 2009 but then slightly declined from 2009 to 2010 not reaching 2008 level. |
| Net income before allocation to noncontrolling interests | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | Pfizer Inc.'s net income before allocation to noncontrolling interests increased from 2008 to 2009 but then slightly declined from 2009 to 2010 not reaching 2008 level. |
| Net income attributable to Pfizer Inc. | The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. | Pfizer Inc.'s net income attributable to Pfizer Inc. increased from 2008 to 2009 but then slightly declined from 2009 to 2010 not reaching 2008 level. |
February 8, 2012